...
首页> 外文期刊>The Lancet infectious diseases >Pathogenesis of filoviral haemorrhagic fevers.
【24h】

Pathogenesis of filoviral haemorrhagic fevers.

机译:丝状出血热的发病机理。

获取原文
获取原文并翻译 | 示例
           

摘要

The filoviruses, marburgvirus and ebolavirus, cause epidemics of haemorrhagic fever with high case-fatality rates. The severe illness results from a complex of pathogenetic mechanisms that enable the virus to suppress innate and adaptive immune responses, infect and kill a broad variety of cell types, and elicit strong inflammatory responses and disseminated intravascular coagulation, producing a syndrome resembling septic shock. Most experimental data have been obtained on Zaire ebolavirus, which causes uniformly lethal disease in experimentally infected non-human primates but produces a broader range of outcomes in naturally infected human beings. 10-30% of patients can survive the illness by mobilising adaptive immune responses, and there is limited evidence that mild or symptomless infections also occur. The other filoviruses that have caused human disease, Sudan ebolavirus, Ivory Coast ebolavirus, and marburgvirus, produce a similar illness but with somewhat lower case-fatality rates. Variations in outcome during an epidemic might be due partly to genetically determined differences in innate immune responses to the viruses. Recent studies in non-human primates have shown that blocking of certain host responses, such as the coagulation cascade, can result in reduced viral replication and improved host survival.
机译:线状病毒,马尔堡病毒和埃博拉病毒引起出血热的流行,病死率很高。严重的疾病是由多种致病机制引起的,该机制使病毒能够抑制先天性和适应性免疫反应,感染并杀死多种细胞类型,并引起强烈的炎症反应和弥散性血管内凝血,从而产生类似于脓毒性休克的综合征。已获得有关扎伊尔埃博拉病毒的大多数实验数据,扎伊尔埃博拉病毒可在受实验感染的非人类灵长类动物中引起均匀致死性疾病,但在自然感染的人类中产生更广泛的结果。 10-30%的患者可通过调动适应性免疫应答而幸存下来,并且仅有有限的证据表明还会发生轻度或无症状的感染。其他引起人类疾病的丝状病毒,苏丹埃博拉病毒,象牙海岸埃博拉病毒和马尔堡病毒也产生类似的疾病,但病死率较低。流行期间结果的变化可能部分归因于对病毒的先天免疫反应的遗传确定差异。最近在非人类灵长类动物中的研究表明,阻断某些宿主反应(例如凝血级联反应)可导致病毒复制减少和宿主存活期延长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号